<?xml version="1.0" encoding="UTF-8"?>
<p id="par0095">Colchicine may be a good therapeutic option for COVID-19. Currently, there are only nine clinical trials considering the clinical utility of colchicine. These include the Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) 
 <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04322682" id="intr0005" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04322682</ext-link>, the only trial recruiting patients, the ECLA PHRI COLCOVID Trial 
 <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04328480" id="intr0010" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04328480</ext-link>, the GReek Study of the Effects of Colchicine on Covid-19 Complication Prevention (GRECCO-19) 
 <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04326790" id="intr0015" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04326790</ext-link>, the Colchicine to Reduce Myocardial Injury in COVID-19 (COLHEART-19) 
 <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04355143" id="intr0020" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04355143</ext-link>, and the Colchicine Counteracting Inflammation in COVID-19 Pneumonia 
 <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04322565" id="intr0025" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04322565</ext-link> among others that will begin recruiting patients shortly. Hopefully, their results will come out soon.
</p>
